, 2019 Subject Explanation and analysis of Management for second quarter 2019 Attention Directors and manager The Stock Exchange of Thailand Inter pharma Public Company Limited (“the Company”) would like
and Manager The Stock Exchange of Thailand According to the resolution of the meeting of the Board of Directors No. 4/2019 of Wattanapat Hospital Trang Public Company Limited (“the Company”) held on 13
73 1 / 4 (Translation) Pef. MD 014/2020 14th May 2020. Subj Management Discussion and Analysis (MD&A) Q1/2020 Dear Managing Director of Stock Exchange of Thailand We, Patum Rice Mill and Granary
No No. CC20200806ELE Aug 13, 2020 Re: Clarification of the changes in operation performance for the second quarter and the first half ended 30 June 2020 Attn: The President The Stock Exchange of
@halcyon.co.th No. CS-2563/014 14 August 2020 Subject: Management Discussion and Analysis for the 6-Month Period Ended 30 June 2020 To: Directors and Managers The Stock Exchange of Thailand Halcyon Technology
27 April 2020 To: The President The Stock Exchange of Thailand Re: Q1-2020 Operating Results We, Delta Electronics (Thailand) Public Company Limited (the “Company”) would like to notify the Company’s
Manager The Stock Exchange of Thailand According to the resolution of the meeting of the Board of Directors No. 3/2020 of Wattanapat Hospital Trang Public Company Limited (“the Company”) held on 13 May 2020
นาสูความเปนเลิศ ทั้งในดานพาณิชยและคุณภาพผลิตภัณฑอยางเปนมืออาชพี” May 15, 2020 Subject: Clarification on the cause of changes in operating results. To: Director and Manager The Stock Exchange of
results for the nine-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech
Page 1 No. CMC Sor Lor.013/2019 Date 12 November 2019 Re: Management Discussion & Analysis for the Period Ended 30 September 2019 To The President of the Stock Exchange of Thailand (SET